Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian studyF Boccardo, A Rubagotti, A Perrotta, et al.European Urology|January 1, 1990
Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Italian Prostatic Cancer Project (PONCAP)F Boccardo, A Decensi, D Guarneri, et al.American Journal of Clinical Oncology|January 1, 1988
Long-acting (depot) D-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trialF Boccardo, A Decensi, D Guarneri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative studyF Boccardo, A Rubagotti, D Amoroso, et al.European Journal of Cancer (Oxford, England : 1990)|February 19, 2013
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: long term results of the Italian Tamoxifen Anastrozole trialF Boccardo, P Guglielmini, R Bordonaro, et al.Seminars in Oncology|December 1, 1988
Etoposide v etoposide and cisplatin in the treatment of advanced non-small cell lung cancer: a FONICAP randomized studyR Rosso, A Ardizzoni, F Salvati, et al.American Journal of Clinical Oncology|December 1, 1993
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuationP Pronzato, A Rubagotti, D Amoroso, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trialP F Conte, P Pronzato, A Rubagotti, et al.Cancer Treatment Reports|July 1, 1986
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lungA Ardizzoni, L Canobbio, P Pronzato, et al.Cancer Investigation|January 1, 1997
Lack of effectiveness of adjuvant alternating chemotherapy in node-positive, estrogen-receptor-negative premenopausal breast cancer patients: results of a multicentric Italian study. The Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group (GROCTA)F Boccardo, A Rubagotti, D Amoroso, et al.Pageof 7